BioXcel Therapeutics (BTAI) Return on Capital Employed Growth (5y) (2023 - 2026)
BioXcel Therapeutics (BTAI) Return on Capital Employed Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.54 Bn | 20.54 Bn | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn |
| 10 | BioXcel Therapeutics | 20.39 Mn | 20.39 Mn | -77,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37,321.00 |
| Dec 31, 2025 | 59,407.00 |
| Sep 30, 2025 | 206,634.00 |
| Jun 30, 2025 | 440,391.00 |
| Mar 31, 2025 | -32,775.00 |
| Dec 31, 2024 | -20,808.00 |
| Sep 30, 2024 | -13,685.00 |
| Jun 30, 2024 | -13,806.00 |
| Mar 31, 2024 | -24,534.00 |
| Dec 31, 2023 | -23,859.00 |
| Sep 30, 2023 | -22,131.00 |
| Jun 30, 2023 | -13,500.00 |
| Mar 31, 2023 | -7,554.00 |